ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1,3,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
1,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1,5,Blood testosterone abnormal,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
1,6,Blood testosterone increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
1,7,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1,10,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1,11,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1,12,Nipple disorder,Breast disorders NEC,Breast disorders,Repro,N
1,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1,14,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1,15,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1,16,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,17,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2,1,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
3,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
3,3,Pelvic inflammatory disease,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
3,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
4,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,2,Inflammatory pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,3,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5,4,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,1,Acne cystic,Acnes,Skin appendage conditions,Skin,N
8,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
8,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
8,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,5,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
9,1,Claustrophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
9,2,Deafness,Hearing losses,Hearing disorders,Ear,N
9,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9,4,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
9,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
